Gemcitabine Hydrochloride in Treating Patients With Locally Advanced Pancreatic Cancer

Clinical trial NCT01893294 · COMPLETED

Trial details

NCT number: NCT01893294
Sponsor: Mayo Clinic
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Duct Cell Adenocarcinoma of the Pancreas Stage III Pancreatic Cancer Stage IV Pancreatic Cancer

Start date: 2013-04-01
Primary completion: 2015-10-30
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.